HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cost-effective treatment of atracurium resistance in critically ill patients.

AuthorsS J Tschida, L L Hoey, K Vance-Bryan
JournalAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (Am J Health Syst Pharm) Vol. 52 Issue 16 Pg. 1818-9 (Aug 15 1995) ISSN: 1079-2082 [Print] England
PMID8528843 (Publication Type: Comparative Study, Letter, Comment)
Chemical References
  • Isoquinolines
  • Neuromuscular Nondepolarizing Agents
  • Atracurium
  • Pancuronium
  • doxacurium
Topics
  • Atracurium (pharmacology)
  • Cost-Benefit Analysis
  • Critical Illness
  • Humans
  • Isoquinolines (economics, therapeutic use)
  • Neuromuscular Nondepolarizing Agents (economics, therapeutic use)
  • Pancuronium (economics, therapeutic use)
  • Tachyphylaxis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: